183 related articles for article (PubMed ID: 36990635)
1. The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases.
Lee SL; Bassetti MF; Rusthoven CG
Semin Radiat Oncol; 2023 Apr; 33(2):181-192. PubMed ID: 36990635
[TBL] [Abstract][Full Text] [Related]
2. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
3. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for oligometastases.
Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
[TBL] [Abstract][Full Text] [Related]
5. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy.
Wang WJ; Chiou JF; Huang Y
J Vis Exp; 2018 May; (135):. PubMed ID: 29806826
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
Doi H; Beppu N; Kitajima K; Kuribayashi K
Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
Klement RJ; Guckenberger M; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Habermehl D; Hildebrandt G; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Andratschke N
Radiother Oncol; 2017 May; 123(2):227-233. PubMed ID: 28274491
[TBL] [Abstract][Full Text] [Related]
11. Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
Henke LE; Stanley JA; Robinson C; Srivastava A; Contreras JA; Curcuru A; Green OL; Massad LS; Kuroki L; Fuh K; Hagemann A; Mutch D; McCourt C; Thaker P; Powell M; Markovina S; Grigsby PW; Schwarz JK; Chundury A
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):379-389. PubMed ID: 34474109
[TBL] [Abstract][Full Text] [Related]
12. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy for liver metastases in oligometastatic disease.
Jaksic N; Modesto A; Meillan N; Bordron A; Michalet M; Riou O; Lisbona A; Huguet F
Cancer Radiother; 2024 Feb; 28(1):75-82. PubMed ID: 37865603
[TBL] [Abstract][Full Text] [Related]
14. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163
[TBL] [Abstract][Full Text] [Related]
15. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
[TBL] [Abstract][Full Text] [Related]
16. Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer.
Sanuki N; Takeda A; Tsurugai Y; Eriguchi T
Jpn J Radiol; 2022 Oct; 40(10):1009-1016. PubMed ID: 35857212
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
18. Oligometastases: history of a hypothesis.
Milano MT; Biswas T; Simone CB; Lo SS
Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
[TBL] [Abstract][Full Text] [Related]
19. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
Niazi T; Elakshar S; Stroian G
Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
[TBL] [Abstract][Full Text] [Related]
20. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
Takeda A; Sanuki N; Kunieda E
World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
